Paul R. Atchison, M.D.
Professional Background: M.D., UAB School of Medicine, 1986
Office: SC 360G1, 1720 7th Ave S, Birmingham AL 35294-0017
Dr. Atchison received his M.D. degree from the UAB School of Medicine in 1986. He completed a three-year residency under Chairman, John N. Whitaker, from 1987-1990, the last year serving as Chief Resident. Dr. Atchison was licensed in June 1987 to practice medicine in the State of Alabama, was board certified in 1987 by the National Board of Medical Examiners, and board certified in 1993 by the American Board of Psychiatry and Neurology.
Dr. Atchison previously served as Director of the American Parkinson's Disease Association Information and Referral Center at UAB, as Director of the Neurology Clerkship for Junior Medical Students, as Director of the Neurology Residency Program, and as Director of the Office of Neurological Education.
Specialty / Interests
Parkinson's disease and other movement disorders.
Special interests are medical management of Parkinson's disease and treatment of dystonia with botulinum toxin injections.Publications
Atchison PR, Taylor A, Citerone D, Zussman B, Friedman C, Hawker N. Linear pharmacokinetic behavior of ropinirole during multiple dosing in patients with Parkinson’s disease, Journal of Clinical Pharmacology; 40:641-646, 2000.
Dymek MP, Atchison PR, Harrell L, Marson DC. Competency to consent to medical treatment in cognitively impaired patients with Parkinson’s disease. Neurology 2001; 56:17-24.
Pankratz N, Nichols WC, Uniacke SK, Halter C, Rudolph A, Shults C, Conneally PM, Foroud T, and the Parkinson Study Group (including Atchison PR). Genome Screen to Identify Susceptibility Genes for Parkinson Disease in a Sample without Parkin Mutations. American Journal of Human Genetics, 71:124-135, 2002.
Parkinson Study Group (including Atchison PR). A controlled Trial of Rasagiline in Early Parkinson Disease.Arch Neurology, 59: 1937-41, 2002.
Reider CR, Halter CA, Castellucio PF, Oakes D, Foroud T, Parkinson Study Group (including Atchison PR). Reliability of reported age at onset for Parkinson’s disease. Movement Disorders, 18(3):275-9, 2003.
Foroud T, Uniacke SK, Liu L, Pankratz N, Rudolph A, Halter C, Shults C, Marder K, Conneally PM, Nichols WC and the Parkinson Study Group (including Atchison PR). Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson Disease.Neurology,60;796-801, 2003.
Pankratz P, Nichols WC, Uniacke SK, Halter C, Rudolph A, Shults C, Conneally PM, Foroud T and the Parkinson Study Group (including Atchison PR). Significant Linkage of Parkinson Disease to Chromosome 2q36-37, American Journal of Human Genetics, 72:1053-1057, 2003.
Atchison PR: Movement Disorders. In: The Year in Neurology 2003. Ed: Faught RE: Clinical Publishing Services, CRC Press: Oxford, UK, 2003.
Dr. Atchison in Health System Directory